177 related articles for article (PubMed ID: 26695143)
1. Testis expressed 19 is a novel cancer-testis antigen expressed in bladder cancer.
Zhong J; Chen Y; Liao X; Li J; Wang H; Wu C; Zou X; Yang G; Shi J; Luo L; Liu L; Deng J; Tang A
Tumour Biol; 2016 Jun; 37(6):7757-65. PubMed ID: 26695143
[TBL] [Abstract][Full Text] [Related]
2. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma.
Tsui KH; Cheng AJ; Chang Pe; Pan TL; Yung BY
Urology; 2004 Oct; 64(4):839-44. PubMed ID: 15491744
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma.
Singh PK; Srivastava AK; Rath SK; Dalela D; Goel MM; Bhatt ML
Immunobiology; 2015 Jan; 220(1):103-8. PubMed ID: 25178936
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder.
Yin B; Liu G; Wang XS; Zhang H; Song YS; Wu B
Urol Oncol; 2012; 30(6):886-92. PubMed ID: 21396841
[TBL] [Abstract][Full Text] [Related]
5. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
[TBL] [Abstract][Full Text] [Related]
6. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder.
Raman JD; Mongan NP; Tickoo SK; Boorjian SA; Scherr DS; Gudas LJ
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8570-6. PubMed ID: 16361539
[TBL] [Abstract][Full Text] [Related]
8. Human germ/stem cell-specific gene TEX19 influences cancer cell proliferation and cancer prognosis.
Planells-Palop V; Hazazi A; Feichtinger J; Jezkova J; Thallinger G; Alsiwiehri NO; Almutairi M; Parry L; Wakeman JA; McFarlane RJ
Mol Cancer; 2017 Apr; 16(1):84. PubMed ID: 28446200
[TBL] [Abstract][Full Text] [Related]
9. Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status.
Maas S; Warskulat U; Steinhoff C; Mueller W; Grimm MO; Schulz WA; Seifert HH
Urology; 2004 Feb; 63(2):392-7. PubMed ID: 14972509
[TBL] [Abstract][Full Text] [Related]
10. The Immune Checkpoint Molecule CD200 Is Associated with Tumor Grading and Metastasis in Bladder Cancer.
Rexin P; Tauchert A; Hänze J; Heers H; Schmidt A; Hofmann R; Hegele A
Anticancer Res; 2018 May; 38(5):2749-2754. PubMed ID: 29715095
[TBL] [Abstract][Full Text] [Related]
11. Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma.
Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
Immunobiology; 2015 Jan; 220(1):68-73. PubMed ID: 25214475
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the wild type p73 gene in human bladder cancer.
Yokomizo A; Mai M; Tindall DJ; Cheng L; Bostwick DG; Naito S; Smith DI; Liu W
Oncogene; 1999 Feb; 18(8):1629-33. PubMed ID: 10102633
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
14. MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas.
Mengus C; Schultz-Thater E; Coulot J; Kastelan Z; Goluza E; Coric M; Spagnoli GC; Hudolin T
Int J Cancer; 2013 May; 132(10):2459-63. PubMed ID: 23125074
[TBL] [Abstract][Full Text] [Related]
15. Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder.
Patard JJ; Brasseur F; Gil-Diez S; Radvanyi F; Marchand M; François P; Abi-Aad A; Van Cangh P; Abbou CC; Chopin D
Int J Cancer; 1995 Feb; 64(1):60-4. PubMed ID: 7665250
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder.
Afsharpad M; Nowroozi MR; Mobasheri MB; Ayati M; Nekoohesh L; Saffari M; Zendehdel K; Modarressi MH
Pathol Oncol Res; 2019 Jan; 25(1):191-199. PubMed ID: 29058301
[TBL] [Abstract][Full Text] [Related]
17. Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
Sharma P; Gnjatic S; Jungbluth AA; Williamson B; Herr H; Stockert E; Dalbagni G; Donat SM; Reuter VE; Santiago D; Chen YT; Bajorin DF; Old LJ
Cancer Immun; 2003 Dec; 3():19. PubMed ID: 14680360
[TBL] [Abstract][Full Text] [Related]
18. [Expression of melanoma antigen gene in urinary transitional cell carcinomas].
Geng L; Yu LZ; Du P; Ma M; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):667-71. PubMed ID: 16008943
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of survivin mRNA expression in bladder transitional cell carcinomas.
Kitsukawa S; Aoyagi T; Noda K; Ito T; Yamamoto Y; Hosoda S; Otsuru N; Matsumoto T
Hinyokika Kiyo; 2008 Feb; 54(2):101-6. PubMed ID: 18323166
[TBL] [Abstract][Full Text] [Related]
20. Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
Du P; Wang S; Tang X; An C; Yang Y; Jiang WG
Anticancer Res; 2017 Aug; 37(8):4499-4505. PubMed ID: 28739745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
